Increase in peg-asparaginase clearance as a predictor for inactivation in patients with acute lymphoblastic leukemia | Leukemia
Managing asparaginase-related toxicity in adult patients - Oncology Nurse Advisor
Consensus expert recommendations for identification and management of asparaginase hypersensitivity and silent inactivation | Haematologica
Bubble plot of the incidence of allergic reactions (sum of allergies... | Download Scientific Diagram
Managing toxicities with asparaginase-based therapies in adult ALL: summary of an ESMO Open–Cancer Horizons roundtable discussion - ScienceDirect
Asparaginase Toxicities: Identification and Management in Patients With Acute Lymphoblastic Leukemia | ONS
Asparaginase: an old drug with new questions - ScienceDirect
How I treat the toxicities of pegasparaginase in adults with acute lymphoblastic leukemia - ScienceDirect
Hypersensitivity reactions to asparaginase therapy in acute lymphoblastic leukemia: immunology and clinical consequences | Future Oncology
(PDF) Alternative algorithm for L-asparaginase allergy in children with acute lymphoblastic leukemia | Selin Aytac - Academia.edu
Intravenous pegylated asparaginase versus intramuscular native Escherichia coli l-asparaginase in newly diagnosed childhood acute lymphoblastic leukaemia (DFCI 05-001): a randomised, open-label phase 3 trial - ScienceDirect
AEA measurements and 95% CI over time in the groups; Allergic reaction... | Download Scientific Diagram
Increase in peg-asparaginase clearance as a predictor for inactivation in patients with acute lymphoblastic leukemia | Leukemia
Detecting and Treating Asparaginase-Related Toxicities in Acute Lymphoblastic Leukemia (Transcript)
How to manage asparaginase hypersensitivity in acute lymphoblastic leukemia | Future Oncology
Managing asparaginase-related toxicity in adult patients - Oncology Nurse Advisor
The severity of asparaginase-induced allergies was correlated with... | Download Scientific Diagram
Pharmacokinetics of very prolonged PEGasparaginase and Erwinia... | Download Scientific Diagram
Safety of mRNA-based COVID-19 vaccination in paediatric patients with a PEG-asparaginase allergy - EJC Paediatric Oncology
PEG - Aspraginaz - Zuvius Lifesciences
Hypersensitivity to Pegylated E.coli asparaginase as first-line treatment in contemporary paediatric acute lymphoblastic leukaemia protocols: a meta-analysis of the Ponte di Legno Toxicity working group - ScienceDirect
Managing Hypersensitivity to Asparaginase in Pediatrics, Adolescents, and Young Adults | Semantic Scholar
Alternative algorithm for L-asparaginase allergy in children with acute lymphoblastic leukemia. | Semantic Scholar
Increase in peg-asparaginase clearance as a predictor for inactivation in patients with acute lymphoblastic leukemia | Leukemia
A Retrospective Chart Review on the Toxicity of Pegylated Asparaginase in Adult Patients with Acute Lymphoblastic Leukemia
Clinical Characteristics of Intravenous PEG-Asparaginase Hypersensitivity Reactions in Patients Undergoing Treatment for Acute Lymphoblastic Leukemia - Emily K. Browne, Christina Moore, April Sykes, Zhaohua Lu, Sima Jeha, Belinda N. Mandrell, 2018
Asparaginase - Wikipedia
